Andreas Argyrides Stock Analyst Profile - Oppenheimer Research Coverage - Stocknear

Andreas Argyrides

Stock Analyst at Oppenheimer

(5)
# 279
Out of 5,506 analysts
122
Total ratings
Success rate
Average return

33 Stocks

Name Action PT Current % Upside Ratings Updated
MNPR Monopar Therapeutics
Maintains: Outperform
77 115
99.39 15.71% 2 Oct 2, 2025
LRMR Larimar Therapeutics
Maintains: Outperform
26 21
4.87 331.21% 2 Oct 2, 2025
BNTC Benitec Biopharma
Maintains: Outperform
35 29
13.84 109.54% 2 Sep 16, 2025
KALA Kala Bio
Maintains: Outperform
15 33
1.54 2042.86% 2 Sep 11, 2025
SVRA Savara
Maintains: Outperform
6 8
3.49 129.23% 1 Sep 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
510 575
453.07 26.91% 1 Sep 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
12 15
5.76 160.42% 2 Sep 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
19 20
5.41 269.69% 2 Aug 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
34 13
13.06 -0.46% 2 Aug 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
61
27.28 123.61% 1 Jun 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
15 7
5.8 20.69% 5 Jun 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
6 3
1.58 89.87% 2 May 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
13
22.43 -42.04% 7 May 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
14 4
0.51 684.31% 5 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
155 90
46.22 94.72% 1 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 9
2.45 267.35% 1 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
47 15
15.94 -5.9% 8 Jan 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
181 181
204.05 -11.3% 9 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
7 7
n/a n/a 1 Aug 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
104
8.43 1133.69% 14 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
75
4.37 1616.25% 1 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
9
2.57 250.19% 7 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
19 19
10.31 84.29% 9 Mar 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
29 29
17.57 65.05% 3 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
21 21
10.43 101.34% 4 Feb 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
224 224
22.64 889.4% 4 Feb 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
57 57
24.84 129.47% 2 Feb 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 6 Nov 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
5 7
0.98 614.29% 3 Oct 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
16 10
0.68 1370.59% 4 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
73 70
55.43 26.29% 6 Aug 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
53 42
n/a n/a 2 Jan 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Aug 8, 2022